They were also correlated with pathways such as metabolic pathways, pathways in cancer, lipid and atherosclerosis, PI3K-Akt signaling pathway, MAPK signaling pathway, chemical carcinogenesis-receptor activation, pathways of neurodegeneration-multiple diseases, and chemical carcinogenesis-reactive oxygen species, suggesting that ACP has a pharmacological role not only in oncological diseases but also in cardiovascular, cerebrovascular, and neurodegenerative-related diseases. This evidence concerns the gene AKT1 and cancer.